Detalhe da pesquisa
1.
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Circulation;
148(9): 753-764, 2023 08 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37439219
2.
Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment-Elevation Myocardial Infarction: Results of REAL-TIMI 63B.
Circulation;
146(12): 907-916, 2022 09 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36039762
3.
Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.
N Engl J Med;
380(16): 1509-1524, 2019 04 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30883055
4.
Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial.
Am Heart J;
251: 1-12, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35533724
5.
Ticagrelor versus clopidogrel after fibrinolytic therapy in patients with ST-elevation myocardial infarction: Rationale and design of the ticagrelor in patients with ST elevation myocardial infarction treated with thrombolysis (TREAT) trial.
Am Heart J;
202: 89-96, 2018 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29908420
6.
Randomized Comparison of Two Approaches to Initial Warfarin Dosing: Time in Therapeutic Range of International Normalized Ratio During Hospitalization.
Kardiologiia;
57(9): 42-46, 2018 Nov 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31713505
7.
Hospitalization Among Patients With Atrial Fibrillation and a Recent Acute Coronary Syndrome or Percutaneous Coronary Intervention Treated With Apixaban or Aspirin: Insights From the AUGUSTUS Trial.
Circulation;
140(23): 1960-1963, 2019 12 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31553201
8.
Association of Cardiac Biomarkers With Major Adverse Cardiovascular Events in High-risk Patients With Diabetes: A Secondary Analysis of the DECLARE-TIMI 58 Trial.
JAMA Cardiol;
8(5): 503-509, 2023 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36857035
9.
Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox.
Clin Cardiol;
42(10): 1028-1040, 2019 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31317575
10.
Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial.
J Am Coll Cardiol;
73(22): 2819-2828, 2019 06 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30898608
11.
Use of ticagrelor alongside fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Practical perspectives based on data from the TREAT study.
Clin Cardiol;
41(10): 1322-1327, 2018 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30098028
12.
Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial.
JAMA Cardiol;
3(5): 391-399, 2018 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29525822
13.
Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in Russia: an observational study (EPICOR-RUS study).
Curr Med Res Opin;
33(7): 1269-1276, 2017 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28420281
14.
Pharmacodynamic and Pharmacokinetic Profiles of Sacubitril/Valsartan (LCZ696) in Patients with Heart Failure and Reduced Ejection Fraction.
Cardiovasc Ther;
34(4): 191-8, 2016 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26990595